Opal Wealth Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,619
Closed -$223K 525
2026
Q1
$223K Buy
4,619
+188
+4% +$8.77K 0.05% 190
2025
Q4
$215K Sell
4,431
-286
-6% -$14.2K 0.06% 192
2025
Q3
$223K Sell
4,717
-1,426
-23% -$68.8K 0.06% 177
2025
Q2
$297K Buy
6,143
+718
+13% +$36.7K 0.08% 141
2025
Q1
$301K Buy
5,425
+331
+6% +$17.9K 0.09% 121
2024
Q4
$246K Sell
5,094
-33
-0.6% -$1.68K 0.07% 152
2024
Q3
$295K Buy
5,127
+538
+12% +$29K 0.09% 126
2024
Q2
$223K Buy
+4,589
New +$221K 0.07% 158

Other funds holding SNY

Opal Wealth Advisors's SNY Position: Q2 2026 in Review

Opal Wealth Advisors sold out of Sanofi (SNY) in Q2 2026, closing a stake of 4,619 shares — an estimated $223K sold.

Opal Wealth Advisors first reported a position in SNY in Q2 2024 and held it in 8 quarters. The position peaked at $301K in Q1 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Opal Wealth Advisors reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Opal Wealth Advisors sold 4,619 Sanofi shares in Q2 2026, an estimated $223K.
  • Opal Wealth Advisors first reported a position in Sanofi in Q2 2024 and held it in 8 quarters.
  • Opal Wealth Advisors's Sanofi position peaked at $301K in Q1 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.